We also know that the two candidates have very different policies and the longer it drags on, the more the uncertainty will be there. And definitely that is a risk that is there in the market. So, it is too difficult to call out how the election will be, clearly. But the uncertainty is creating some concern for the investors. But people like us, we basically try to take advantage of that, so we are okay.
Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downside
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a
November 5, 2024